Cited by 54

The DOI matches its Crossref record.

Inhibition of Bax activity is crucial for the antiapoptotic function of the human papillomavirus E6 oncoprotein

Vogt, M, Butz, K, Dymalla, S, Semzow, J, Hoppe-Seyler, F·2006·Oncogene

Abstract

Oncogenic types of human papillomaviruses (HPVs) cause cervical cancer in humans. The antiapoptotic viral E6 gene has been identified as a key factor for maintaining the viability of HPV-positive cancer cells. Although E6 has the potential to modulate many apoptosis regulators, the crucial apoptotic pathway blocked by endogenous E6 in cervical cancer cells remained unknown. Using RNA interference (RNAi), here, we show that targeted inhibition of E6 expression in cervical cancer cells leads to the transcriptional stimulation of the PUMA promoter, in a p53-dependent manner. This is linked to the activation and translocation of Bax to the mitochondrial membrane, cytochrome c release into the cytosol, and activation of caspase-3, in a PUMA-dependent manner. Moreover, inhibition of Bax expression by RNAi efficiently reverts the apoptotic phenotype, which results from inhibition of E6 expression. Thus, interference with the p53/PUMA/Bax cascade is crucial for the antiapoptotic function of the viral E6 oncogene in HPV-positive cancer cells.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.onc.1209429

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 36

  1. Aguilar-Lemarroy A, Gariglio P, Whitaker NJ, Gariglio P, zur Hausen H, Krammer PH et al. (2002). Oncogene 21: 165–175. · DOI
  2. Baldus SE, Schwarz E, Lohrey C, Zapatka M, Landsberg S, Hahn SA et al. (2005). Oncogene 24: 810–819. · DOI
  3. Brummelkamp TR, Bernards R, Agami R . (2002). Science 296: 550–553. · DOI
  4. Butz K, Denk C, Ullmann A, Scheffner M, Hoppe-Seyler F . (2000). Proc Natl Acad Sci USA 97: 6693–6697. · DOI
  5. Butz K, Ristriani T, Hengstermann A, Denk C, Scheffner M, Hoppe-Seyler F . (2003). Oncogene 22: 5938–5945. · DOI · Paper page
  6. Chen C, Okayama H . (1987). Mol Cell Biol 7: 2745–2752. · DOI
  7. DeFilippis RA, Goodwin EC, Wu L, DiMaio D . (2003). J Virol 77: 1551–1563. · DOI
  8. Desaintes C, Goyat S, Garbay S, Yaniv M, Thierry F . (1999). Oncogene 18: 4538–4545. · DOI
  9. Evan GI, Vousden KH . (2001). Nature 411: 342–348. · DOI · Paper page
  10. Filippova M, Parkhurst L, Duerksen-Hughes PJ . (2004). J Biol Chem 279: 25729–25744. · DOI · Paper page
  11. Goodwin EC, Yang E, Lee CJ, Lee HW, DiMaio D, Hwang ES . (2000). Proc Natl Acad Sci USA 97: 10978–10983. · DOI · Paper page
  12. Gu J, Zhang L, Swisher SG, Liu J, Roth JA, Fang B . (2004). Oncogene 23: 1300–1307. · DOI
  13. Hall AH, Alexander KA . (2003). J Virol 77: 6066–6069. · DOI
  14. Hengstermann A, D'silva MA, Kuballa P, Butz K, Hoppe-Seyler F, Scheffner M . (2005). J Virol 79: 9296–9300. · DOI · Paper page
  15. Horner SM, DeFilippis RA, Manuelidis L, DiMaio D . (2004). J Virol 78: 4063–4073. · DOI
  16. Hsu YT, Youle RJ . (1998). J Biol Chem 273: 10777–10783. · DOI
  17. Kaeser MD, Iggo RD . (2002). Proc Natl Acad Sci USA 99: 95–100. · DOI
  18. Kelley ML, Keiger KE, Lee CJ, Huibregtse JM . (2005). J Virol 79: 3737–3747. · DOI
  19. Klingelhutz AJ, Foster SA, McDougall JK . (1996). Nature 380: 79–82. · DOI · Paper page
  20. Kong XT, Gao H, Stanbridge EJ . (2001). J Biol Chem 276: 32990–33000. · DOI
  21. Liu J, Wei T, Kwang J . (2004). Virology 318: 169–182. · DOI
  22. Magal SS, Jackman A, Ish-Shalom S, Botzer LE, Gonen P, Schlegel R et al. (2005). J Gen Virol 86: 611–621. · DOI
  23. Melino G, Bernassola F, Ranalli M, Yee K, Zong WX, Corazzari M et al. (2004). J Biol Chem 279: 8076–8083. · DOI · Paper page
  24. Miyashita T, Reed JC . (1995). Cell 80: 293–299. · DOI · Paper page
  25. Nakano K, Vousden KH . (2001). Mol Cell 7: 683–694. · DOI · Paper page
  26. Pan H, Griep AE . (1995). Genes Dev 9: 2157–2169. · DOI
  27. Psyrri A, DeFilippis RA, Edwards AP, Yates KE, Manuelidis L, DiMaio D . (2004). Cancer Res 64: 3079–3086. · DOI
  28. Samali A, Cai J, Zhivotovsky B, Jones DP, Orrenius S . (1999). EMBO J 18: 2040–2048. · DOI
  29. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM . (1990). Cell 63: 1129–1136. · DOI · Paper page
  30. Stöppler H, Conrad Stöppler M, Johnson E, Simbulan-Rosenthal CM, Smulson ME, Iyer S et al. (1998). Oncogene 17: 1207–1214. · DOI
  31. Thomas M, Banks L . (1998). Oncogene 17: 2943–2954. · DOI · Paper page
  32. Wells SI, Francis DA, Karpova AY, Dowhanick JJ, Benson JD, Howley PM . (2000). EMBO J 19: 5762–5771. · DOI
  33. Yu L, Zhang L, Hwang PM, Kinzler KW, Vogelstein B . (2001). Mol Cell 7: 673–682. · DOI
  34. Yuan H, Fu F, Zhuo J, Wang W, Nishitani J, An DS et al. (2005). Oncogene 24: 5069–5078. · DOI
  35. Zhang HM, Yuan J, Cheung P, Chau D, Wong BW, MacManus BM et al. (2005). Mol Cell Biol 25: 6247–6258. · DOI
  36. zur Hausen H . (2002). Nat Rev Cancer 2: 342–350. · DOI

Metadata

Authors
Vogt, M., Butz, K., Dymalla, S., Semzow, J., & Hoppe-Seyler, F.
Venue
Oncogene
Published
2006-02-06
Volume
25
Issue
29
Pages
4009-4015
ISSN
  • 0950-9232
  • 1476-5594
Cited by
54
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inhibition of Bax activity is crucial for the antiapoptotic function of the human papillomavirus E6 oncoprotein. https://app.cochat.ai/papers/10.1038/sj.onc.1209429
The paper
Vogt, M., Butz, K., Dymalla, S., Semzow, J., & Hoppe-Seyler, F. (2006). Inhibition of Bax activity is crucial for the antiapoptotic function of the human papillomavirus E6 oncoprotein. Oncogene. https://doi.org/10.1038/sj.onc.1209429